Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings results on February 11, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings results on February 11, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.47, beating the consensus estimate of $1.33 by $0.14 per share. Revenue came in at $622.0M, missing the estimate of $832.6M.
Royalty Pharma's stock moved following the earnings release. The stock currently trades at $44.26 with a market capitalization of $16.8B.
Current market data
NASDAQ · RPRX
$63.96
Up: +$0.08 · +0.13%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
dividends ·
sec_filing ·
sec_filing ·
institutional ·
